# An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limited Kidney Function

> **NCT00718640** · PHASE2 · TERMINATED · sponsor: **Janssen-Ortho Inc., Canada** · enrollment: 10 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Bortezomib

## Key facts

- **NCT ID:** NCT00718640
- **Lead sponsor:** Janssen-Ortho Inc., Canada
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2009-12
- **Final completion:** 2010-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Study stopped due to lagging enrolment.
- **Last updated:** 2013-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00718640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00718640, "An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limited Kidney Function". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00718640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*